Explore <strong>Temazepam</strong>, a benzodiazepine primarily used for short-term insomnia treatment. Learn about its dosage, potential side effects, and how it helps improve sleep quality.
Browse our catalog for available pharmaceutical products and competitive pricing.
Temazepam is a pharmaceutical compound belonging to the benzodiazepine class of medications, primarily prescribed for the short-term treatment of insomnia. It exerts its effects by depressing the central nervous system, leading to sedation, hypnosis, anxiolysis, anticonvulsant activity, and muscle relaxation. First synthesized in 1964 and introduced to medical practice in the 1970s, Temazepam quickly became a widely used hypnotic agent due to its relatively rapid onset of action and intermediate duration, making it suitable for individuals struggling with sleep initiation and maintenance.
As a benzodiazepine, Temazepam is classified under the Anatomical Therapeutic Chemical (ATC) code N05CD07, which falls within the broader N05 category for psycholeptics, specifically hypnotics and sedatives. Its chemical structure is 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one. This molecular configuration is critical for its interaction with specific receptors in the brain, which ultimately mediates its therapeutic effects. Unlike some other benzodiazepines, Temazepam is an active metabolite of diazepam and oxazepam, meaning it is already in an active form and does not require extensive hepatic metabolism before exerting its effects, which can be an advantage in certain patient populations.
The development of Temazepam marked a significant advancement in the pharmacological management of sleep disorders. Prior to its introduction, many available hypnotics had less favorable side effect profiles or higher risks of dependence. While Temazepam, like all benzodiazepines, carries risks of dependence and withdrawal, its pharmacokinetic properties, particularly its intermediate half-life, were considered beneficial for reducing daytime sedation while still providing effective nighttime sleep. It remains an important medication in the short-term management of severe, disabling, or distressing insomnia, always emphasizing the importance of a comprehensive treatment plan that may include non-pharmacological interventions.
The therapeutic effects of Temazepam are primarily mediated through its action on the gamma-aminobutyric acid (GABA) type A (GABA-A) receptors in the central nervous system (CNS). GABA is the principal inhibitory neurotransmitter in the brain, and when it binds to GABA-A receptors, it causes an influx of chloride ions into the neuron, leading to hyperpolarization and a reduction in neuronal excitability. Temazepam, as a benzodiazepine, does not directly activate the GABA-A receptor but rather acts as a positive allosteric modulator. This means it binds to a specific, distinct site on the GABA-A receptor complex, separate from the GABA binding site, and enhances the affinity of GABA for its receptor.
By increasing the frequency of chloride channel opening in the presence of GABA, Temazepam amplifies GABA's inhibitory effects, leading to widespread CNS depression. This enhanced inhibition is responsible for the diverse pharmacological actions of Temazepam, including its hypnotic (sleep-inducing), sedative, anxiolytic (anti-anxiety), anticonvulsant, and muscle relaxant properties. The specific subunit composition of GABA-A receptors varies throughout the brain, and benzodiazepines like Temazepam exhibit some selectivity for receptors containing alpha-1, alpha-2, alpha-3, and alpha-5 subunits, with the alpha-1 subunit being particularly implicated in hypnotic effects.
Temazepam is a prescription medication primarily indicated for the short-term management of insomnia. Its efficacy in helping individuals fall asleep faster and stay asleep longer has made it a valuable tool in addressing acute and chronic sleep disturbances. Due to its potential for dependence and withdrawal, its use is generally limited to periods of 7 to 10 consecutive days, or as directed by a healthcare professional for specific short-term needs.
The dosage of Temazepam must be individualized based on the patient's condition, age, body weight, and response to therapy. It is crucial to start with the lowest effective dose and use it for the shortest possible duration to minimize the risk of dependence and adverse effects. Temazepam is typically administered orally, shortly before bedtime, usually 30 minutes prior to the desired sleep time. It should not be taken with alcohol or other CNS depressants.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Insomnia (Adults) | 7.5 mg - 30 mg | Once daily at bedtime | Oral |
| Insomnia (Elderly/Debilitated) | 7.5 mg - 15 mg | Once daily at bedtime | Oral |
| Severe Insomnia (Adults) | 30 mg | Once daily at bedtime | Oral |
Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition. Never exceed the prescribed dose or duration of treatment. Abrupt discontinuation of Temazepam after prolonged use can lead to withdrawal symptoms, so tapering the dose under medical supervision is often necessary.
Like all medications, Temazepam can cause side effects, though not everyone experiences them. The incidence and severity of side effects are often dose-dependent and can be more pronounced in older adults or those with underlying health conditions. It is important to report any unusual or bothersome symptoms to your healthcare provider.
Temazepam can interact with various other medications, potentially altering its effects or increasing the risk of adverse reactions. It is crucial to inform your doctor and pharmacist about all prescription, over-the-counter, and herbal supplements you are taking before starting Temazepam to prevent dangerous interactions. The most significant interactions involve other central nervous system depressants.
Temazepam is not suitable for everyone and has several contraindications and important warnings that must be considered by healthcare providers before prescribing. Adherence to these guidelines is crucial for patient safety.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.
Temazepam is generally not recommended for long-term use. Its efficacy for insomnia beyond 7 to 10 days has not been established in controlled clinical trials, and prolonged use significantly increases the risk of physical and psychological dependence, tolerance, and withdrawal symptoms upon discontinuation. Healthcare professionals typically advise its use for the shortest possible duration to manage acute insomnia episodes.
Temazepam can be taken with or without food. However, taking it with a heavy, high-fat meal might slightly delay its absorption and the onset of its effects. For optimal results, it is often recommended to take Temazepam on an empty stomach about 30 minutes before bedtime, but following your prescriber's specific instructions is always paramount.
If you miss a dose of Temazepam and it's still early in the night and you still have several hours left for sleep, you may take the missed dose. However, if it's already close to your usual wake-up time or you don't have enough time for a full night's sleep (at least 7-8 hours), it's best to skip the missed dose and resume your regular schedule the next night. Do not take a double dose to make up for a missed one, as this can increase the risk of excessive sedation and other side effects.
Temazepam is a controlled substance and a prescription-only medication. This means it cannot be bought over-the-counter or without a valid prescription from a licensed healthcare provider. You can obtain Temazepam from a licensed pharmacy after receiving a prescription. Purchasing Temazepam through unofficial or unregulated channels is illegal and highly dangerous due to the risk of counterfeit products, incorrect dosages, and lack of medical supervision.